Login
$NRIX
$14.92 +$0.19 (1.29%) After hours

Insider Transactions

What Nurix Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 15 48
Total trades 31 105

Shares traded

3 months 12 months
Acquired 74,844 295,015
Disposed 70,744 289,652
Net activity +4,100 +5,363

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
van Houte Hans Chief Financial Officer Nov 04 Open-market sale · S −1,469 $16.20 −$23.8K 42,745
van Houte Hans Chief Financial Officer Nov 04 Open-market sale · S −3,300 $15.38 −$50.8K 44,214
Ring Christine Chief Legal Officer Nov 03 Open-market sale · S −6,113 $25.83 −$158K 4,406
Ring Christine Chief Legal Officer Nov 02 Open-market sale · S −1,075 $26.76 −$28.8K 10,519
Ring Christine Chief Legal Officer Nov 02 Open-market sale · S −9,527 $25.74 −$245K 11,594
Ring Christine Chief Legal Officer Nov 02 Exercise / conversion · M +5,786 $8.72 +$50.5K 21,121
Hansen Gwenn Chief Scientific Officer Nov 02 Open-market sale · S −1,452 $26.80 −$38.9K 123,452
Hansen Gwenn Chief Scientific Officer Nov 02 Exercise / conversion · M +1,452 $1.86 +$2.7K 124,904
Ring Christine Chief Legal Officer Oct 30 Open-market sale · S −3,957 $26.28 −$104K 15,335
Ring Christine Chief Legal Officer Oct 30 Exercise / conversion · M +3,573 — — 19,292
Ring Christine Chief Legal Officer Oct 30 Exercise / conversion · M +2,859 — — 15,719
Ring Christine Chief Legal Officer Oct 30 Exercise / conversion · M +3,750 — — 12,860
van Houte Hans Chief Financial Officer Oct 30 Open-market sale · S −2,834 $26.28 −$74.5K 47,514
van Houte Hans Chief Financial Officer Oct 30 Exercise / conversion · M +3,573 — — 50,348
van Houte Hans Chief Financial Officer Oct 30 Exercise / conversion · M +2,859 — — 46,775
van Houte Hans Chief Financial Officer Oct 30 Exercise / conversion · M +3,750 — — 43,916
Hansen Gwenn Chief Scientific Officer Oct 30 Open-market sale · S −3,957 $26.28 −$104K 123,452
Hansen Gwenn Chief Scientific Officer Oct 30 Exercise / conversion · M +3,573 — — 127,409
Hansen Gwenn Chief Scientific Officer Oct 30 Exercise / conversion · M +2,859 — — 123,836
Hansen Gwenn Chief Scientific Officer Oct 30 Exercise / conversion · M +3,750 — — 120,977

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support